Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 18

    Healthcare sector adversely impacted due to NPPA regulatory measures: ICRA

    Healthcare sector adversely impacted due to NPPA regulatory measures: ICRA

    Meghna A Singhania15 Oct 2019 5:11 PM IST
    The sector’s performance had been adversely impacted in the past two years due to several regulatory measures, including the cap on prices of stents...
    Govt to introduce NEW definition of Medical Devices: Report

    Govt to introduce NEW definition of Medical Devices: Report

    Farhat Nasim14 Oct 2019 4:29 PM IST
    New Delhi: The government is going to adopt another definition of medical devices in order to include more medical equipment under its ambit, a recent...
    CDSCO adds another port for enhancing import of drugs

    CDSCO adds another port for enhancing import of drugs

    Farhat Nasim13 Oct 2019 3:37 PM IST
    New Delhi: Through a recent Gazette notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has apprised about...
    Regulation of all medical devices: DoP, AiMeD, Biotech Consortium to create comprehensive roadmap

    Regulation of all medical devices: DoP, AiMeD, Biotech Consortium to create comprehensive roadmap

    Farhat Nasim13 Oct 2019 9:40 AM IST
    New Delhi: At a recent conference, jointly organized by Department of Pharmaceuticals (DoP), Association of Indian Medical Device Industry (AiMeD) and...
    Punjab: Chemist shot for denying habit-forming drug to patient

    Punjab: Chemist shot for denying habit-forming drug to patient

    Farhat Nasim12 Oct 2019 3:36 PM IST
    The chemist tried to explain to him the restrictions imposed on providing habit-forming drugs sans prescription. However, the miscreants fired at him...
    Accused of Swindling lakhs of rupees, Pharma sales representative hangs self

    Accused of Swindling lakhs of rupees, Pharma sales representative hangs self

    Farhat Nasim11 Oct 2019 3:05 PM IST
    The incident triggered everyone and the deceased's kin filed a complaint with the Byatarayanapura police alleging that the pharma firm's manager...
    Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

    Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

    Farhat Nasim10 Oct 2019 5:01 PM IST
    Dr Reddy's Labs' Chairman, Satish Reddy played a key role in shaping policies concerning the pharmaceutical sector as well as the economy, such as...
    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Medical Dialogues Bureau9 Oct 2019 4:24 PM IST
    Johnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
    Regulatory interventions constraining Profitability of Indian pharma: ICRA

    Regulatory interventions constraining Profitability of Indian pharma: ICRA

    Medical Dialogues Bureau8 Oct 2019 4:53 PM IST
    "But revenues continue to be impacted by price erosion, product rationalisation and continued effect of regulatory overhang for certain companies...
    CDSCO Committee to draft new guidelines for effective recall of substandard drugs

    CDSCO Committee to draft new guidelines for effective recall of substandard drugs

    Farhat Nasim7 Oct 2019 5:29 PM IST
    New Delhi: To examine the issues regarding effective recall system of drugs found Not of Standard Quality (NSQ) and to review the recall guidelines...
    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

    Farhat Nasim6 Oct 2019 11:10 AM IST
    New Delhi: In a relief to the pharmaceutical giant in a trademark matter, the Delhi High Court has recently restrained the manufacture or sale of...
    CDSCO approves SCTIMST as Medical Device Testing Lab

    CDSCO approves SCTIMST as Medical Device Testing Lab

    Farhat Nasim5 Oct 2019 3:16 PM IST
    New Delhi: Through a recent notification, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has given its approval to...
    PrevNext

    Popular Stories

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok